Compass therapeutics to participate in the cantor fitzgerald future of oncology symposium

Boston, march 28, 2023 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the cantor fitzgerald future of oncology symposium, which is taking place virtually on april 3 – 5, 2023.
CMPX Ratings Summary
CMPX Quant Ranking